This presentation provides an introduction to The Edmonton Protocol, which was published …
This presentation provides an introduction to The Edmonton Protocol, which was published back in year 2000 from University of Edmonton. In continuation of this, we’ll talk about insulin injections and hypoglycemia.
Course responsible: Associate Professor Signe Sørensen Torekov, MD Nicolai Wewer Albrechtsen & Professor Jens Juul Holst
This presentation discusses the possibility of finding a cure for type 1 …
This presentation discusses the possibility of finding a cure for type 1 diabetes, and hereby developing a product, that maintains a normal blood glucose level without insulin treatment. In continuation of this, we’ll provide an introduction to beta cell replacement therapy based on The Edmonton Protocol, however we’ll be focusing on relying on stem cell technology rather than that of organ donor islets. Furthermore we’ll discuss how we can combine an encapsulation strategy, so we can avoid the use of immuno-suppression.
Course responsible: Associate Professor Signe Sørensen Torekov, MD Nicolai Wewer Albrechtsen & Professor Jens Juul Holst
In this presentation we’ll take a closer look at the relation between …
In this presentation we’ll take a closer look at the relation between obesity and diabetes. Although it may seem simple, there are various aspects that make the relation between obesity and diabetes, more complex than at first sight.
Course responsible: Associate Professor Signe Sørensen Torekov, MD Nicolai Wewer Albrechtsen & Professor Jens Juul Holst
In this lecture we’ll discuss the role of inflammation in type 2 …
In this lecture we’ll discuss the role of inflammation in type 2 diabetes. In patients with type 2 diabetes, cardiovascular complications are of particular interest, as these are mainly responsible for the increase of mortality and obesity in diabetic patients compared with healthy subjects. In continuation of this and in order to understand why diabetes is an inflammatory disease, we’ll provide an introduction to the acute phase response.
Course responsible: Associate Professor Signe Sørensen Torekov, MD Nicolai Wewer Albrechtsen & Professor Jens Juul Holst
In this presentation we’ll translate our knowledge from genetics into clinically relevant …
In this presentation we’ll translate our knowledge from genetics into clinically relevant patient stories. We’ll present case stories of translational metabolism, which means that we go from genotype to phenotype. Translational science is a multidisciplinary form of science that bridges the gap between basic science and applied science.
Course responsible: Associate Professor Signe Sørensen Torekov, MD Nicolai Wewer Albrechtsen & Professor Jens Juul Holst
In this presentation aim to increase the student’s knowledge about translational metabolism, …
In this presentation aim to increase the student’s knowledge about translational metabolism, in continuation of this we’ll elaborate on topics related to food ingestion, bone resorption, the intestinale hormone GIP, genetic variation in the receptor of GIP in relation to fracture risk, food availability and bone regulation, blood glucose and future treatment of osteoporosis.
Course responsible: Associate Professor Signe Sørensen Torekov, MD Nicolai Wewer Albrechtsen & Professor Jens Juul Holst
This presentation discuss how to treat hyperglycaemia in patients with type 2 …
This presentation discuss how to treat hyperglycaemia in patients with type 2 diabetes. The cornerstone in the treatment is weight loss and increased physical activity, but most patients need pharmacological treatment from the time of diagnosis in order to control hyperglycemia. Furthermore we’ll discuss the use of all diabetic agents in patient with type 2 diabetes and how it’s important that the anti diabetic treatment is individualized.
Course responsible: Associate Professor Signe Sørensen Torekov, MD Nicolai Wewer Albrechtsen & Professor Jens Juul Holst
This presentation discuss the new antidiabetic agents. We have the incretin based …
This presentation discuss the new antidiabetic agents. We have the incretin based therapy which include two groups of drugs, DDP-4 inhibitors and GLP-1 receptor agonist. Furthermore we’ll provide an introduction to the hormones GLP-1 and GIP and their effect on insulin.
Course responsible: Associate Professor Signe Sørensen Torekov, MD Nicolai Wewer Albrechtsen & Professor Jens Juul Holst
This presentation focuses on the treatment of hyperglycaemia with type 2 diabetes …
This presentation focuses on the treatment of hyperglycaemia with type 2 diabetes patients. We’ll provide an introduction to exenatide, liraglutide, GLP-1 receptor antagonist, combination therapy, DPP-4 inhibitor, pancreatic safety of incretin-based drugs, SGLT-2 inhibitor and glucose absorption.
Course responsible: Associate Professor Signe Sørensen Torekov, MD Nicolai Wewer Albrechtsen & Professor Jens Juul Holst
This presentation provides an introduction to Sodium-glucose linked transporter 2 inhibitors (SGLT-2) …
This presentation provides an introduction to Sodium-glucose linked transporter 2 inhibitors (SGLT-2) and how it affects the blood glucose. Furthermore we’ll discuss how SGLT-2 inhibitors can be used for treating patients with type 2 diabetes. Three SGLT-2 inhibitors have been approved: Dapa, Empa and Canagliflozin, for clinical use in patients with type 2 diabetes.
Course responsible: Associate Professor Signe Sørensen Torekov, MD Nicolai Wewer Albrechtsen & Professor Jens Juul Holst
This patient education program explains how diabetes affects eyesight, specifically the prevention …
This patient education program explains how diabetes affects eyesight, specifically the prevention and treatment of diabetic retinopathy. It also reviews eye anatomy, other eye problems, and their treatment. This resource is a MedlinePlus Interactive Health Tutorial from the National Library of Medicine, designed and developed by the Patient Education Institute.
This diabetes self-management case is being utilized in the dietetic internship program …
This diabetes self-management case is being utilized in the dietetic internship program courses at Iowa State University: FSHN 554, 555, & 556 and was designed to increase student confidence in suggesting appropriate recommendations for the medication, blood sugar, and diet management aspects for someone with Type 2 diabetes. As a distance education program, the dietetic internship faculty have created various simulations and case studies for students to gain practice and confidence in providing appropriate patient care. 1. Complete the diabetes self-management case: https://rise.articulate.com/share/wycLssQVOP7tsDhoY2o-KQUWacAChpqH 2. Compare your responses to the expert feedback.
This patient education program explains what diabetes is, the signs and symptoms, …
This patient education program explains what diabetes is, the signs and symptoms, treatment options, hyperglycemia and hypoglycemia, complications, and management of the disease. This resource is a MedlinePlus Interactive Health Tutorial from the National Library of Medicine, designed and developed by the Patient Education Institute.
This presentation focus on the question: can we cure diabetes? By interviewing …
This presentation focus on the question: can we cure diabetes? By interviewing different experts we will estimate how possible it is that we will find a cure for diabetes in the future. One of the main arguments is that we already have a cure, which is eating right and exercise, but the big question is whether people are willing to take this cure?
This presentation discuss how we can fight the global diabetes epidemic. According …
This presentation discuss how we can fight the global diabetes epidemic. According to WHO (2016) the incidence and impacts of diabetes can largely be prevented or reduced with an approach that incorporates evidence-based, affordable, cost-effective, population-wide and multi-sector intervention. So which interventions should we prioritize as the most efficient interventions to fight the global diabetes epidemic?
Many people exercise and take medicine in order to delay or treat …
Many people exercise and take medicine in order to delay or treat type 2 diabetes. However in most cases these interventions in one’s lifestyle fails and the person regain weight and retain their increasing blood glucose levels. Controlling one’s appetite seems to be the key, which is one of the aspects we’ll discuss in this presentation. Furthermore we’ll discuss how gastric bypass surgery helps people with diabetes type 2 controlling their appetite and make their diabetes disappear. Finally we’ll discuss how hormones such as GLP-1 can help diabetics’ control their appetite, and lose weight.
This presentation talks about which role exercise plays in developing diabetes. We …
This presentation talks about which role exercise plays in developing diabetes. We will describe what happens in the body when we exercise, and why these changes help us prevent and treat diabetes. In continuation of this we’ll talk about the interaction between insulin, glucose and muscle cells and how we through exercise, can change our health. Furthermore we’ll discuss how lifestyle can affect one’s future children in terms of developing diabetes later on.
This presentation focus on which role nutrition plays in developing diabetes and …
This presentation focus on which role nutrition plays in developing diabetes and how obesity affects diabetes development. Obesity and weight gain dramatically increase the risk of developing type 2 diabetes. But it’s not only the total calorie intake and the BMI that counts, so does the distribution between fat, protein and carbohydrates, in other words the composition of nutritions. In continuation of this it will be discussed how a restricting intake of carbohydrates might be the way to reduce or even eliminate the use of medication in diabetes treatments.
This presentation address how being overweight and obese is considered one of …
This presentation address how being overweight and obese is considered one of the strongest predictors, regarding the development of type 2 diabetes. Almost 85 % of people living with diabetes type 2, are either overweight or obese. This is an important aspect, because globally we have a lot of overweight people, in fact in 2014, one in three adults was overweight and one in eight was obese. But why do the numbers keep growing and what’s causing this epidemic growth of obesity?
This presentation provides an introduction to Diabetes.What is diabetes and what happens …
This presentation provides an introduction to Diabetes.What is diabetes and what happens in the body? You will learn how diabetes is a term used to describe the body’s inability to produce sufficient amounts of insulin and how insulin as a pancreatic hormone functions as a main glucose regulator, that makes sure our glucose levels are balanced. Both high and low blood glucose levels are dangerous. When you have diabetes, the lack of insulin will cause high blood glucose levels, which affects several parts of your body.
No restrictions on your remixing, redistributing, or making derivative works. Give credit to the author, as required.
Your remixing, redistributing, or making derivatives works comes with some restrictions, including how it is shared.
Your redistributing comes with some restrictions. Do not remix or make derivative works.
Most restrictive license type. Prohibits most uses, sharing, and any changes.
Copyrighted materials, available under Fair Use and the TEACH Act for US-based educators, or other custom arrangements. Go to the resource provider to see their individual restrictions.
